SALEM INVESTMENT COUNSELORS INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 884423
WINSTON-SALEM, NC
Position in VRTX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$245,384
+$24,794 QoQ
Shares Held
494
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#225
of 331 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $2,462,425 across 22 Biotechnology names. VRTX ranks #2 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
100,000 | $1,782,000 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
494 | $245,384 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
5,746 | $99,980 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
2,288 | $89,254 | |
| 5 | INCY |
Incyte Corp
|
779 | $88,307 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
2,675 | $45,394 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
1,000 | $32,230 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
535 | $29,178 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,384 | 494 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $220,590 | 494 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $223,959 | 494 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $140,598 | 359 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $219,928 | 494 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $155,142 | 320 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $104,299 | 259 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $120,455 | 259 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $121,398 | 259 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $107,846 | 258 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $104,977 | 258 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $90,412 | 260 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $90,792 | 258 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $81,288 | 258 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $57,756 | 200 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $57,908 | 200 | Shares | Sole | 2022-11-09 | |
| 2021-12-31 | $408,675 | 1,861 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $333,576 | 1,839 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $371,200 | 1,841 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $429 | 2 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,490 | 19 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||